We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
-4.3%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$352M
AUM Growth
+$167M
(+90%)
Cap. Flow
+$201M
Cap. Flow
% of AUM
57.28%
Top 10 Holdings %
Top 10 Hldgs %
48.24%
Holding
40
New
21
Increased
2
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$14.8M |
| 2 |
SLB Ltd
SLB
|
+$14.7M |
| 3 |
Dick's Sporting Goods
DKS
|
+$14.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$13.5M |
| 5 |
Lockheed Martin
LMT
|
+$13.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.05% |
| 2 | Technology | 21.71% |
| 3 | Industrials | 13.13% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 11.49% |
Similar funds
VM
SSC
I
ACM
MCM
MIA
SP
TI
Howard Hughes Medical Institute's Q3 2022 Portfolio in Review
As of Q3 2022, Howard Hughes Medical Institute held 40 positions worth $352M, up 90% from $185M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Howard Hughes Medical Institute deployed $201M of net new capital in Q3 2022, opening 21 new positions and adding to 2 existing holdings. Its largest new stake was Ralph Lauren: 157,000 shares worth $13.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
- Howard Hughes Medical Institute's largest Q3 2022 buy was Ralph Lauren: 157,000 shares worth $13.3M.
- Howard Hughes Medical Institute added most to Alphabet (Google) Class C in Q3 2022, an estimated $11.7M increase.
- Howard Hughes Medical Institute's ten largest holdings make up 48% of its $352M portfolio in Q3 2022.
- Howard Hughes Medical Institute opened 21 new positions and closed 0 in Q3 2022.
- Howard Hughes Medical Institute's portfolio value rose 90% quarter-over-quarter to $352M.
Based on Howard Hughes Medical Institute's 13F filing for Q3 2022, filed 14 Nov 2022.